Cannabis Stocks Drop After Early Surge on Limited US Marijuana Rescheduling Move
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
Cannabis stocks fell after hype faded: US reform helps medical marijuana only, not full market, so investors took profits.
Regeneron will cut U.S. drug prices, offer free gene therapy for hearing loss, and align costs with other countries under a Trump deal.
The Trump administration is close to approving up to $500 million rescue financing for Spirit Airlines.
The Trump administration is expected to reclassify marijuana from Schedule I to Schedule III as soon as this week, easing research barriers after months of delay.
DOJ may sue Cal-Maine Foods and Versova for possibly coordinating to keep egg prices high during bird flu shortages.
Trump plans to boost research on ibogaine for PTSD in veterans, despite safety concerns and its illegal status in the US.